
zzso factors for unscheduled interruptions in zzso courses completed between June 1989 and August 1995, lasting zzso or zzso 2 days, and associated with World Health Organization grade zzso zzso or zzso were studied zzso A group of controls was randomly zzso Potential risk factors for zzso were analyzed using zzso and zzso zzso The most important risk factors for treatment interruption with zzso were concurrent chemotherapy zzso ratio zzso zzso P zzso zzso increasing percentage of zzso zzso zzso zzso for each zzso P zzso zzso and brain zzso zzso zzso P zzso zzso Other significant zzso zzso zzso factors were zzso bone or bone zzso zzso and prior zzso The most important risk factors for treatment interruptions with zzso were concurrent chemotherapy zzso zzso P zzso zzso and increasing percentage of zzso zzso zzso zzso for each zzso P zzso zzso Similarly, the most important risk factors for treatment interruptions with both zzso and zzso were concurrent chemotherapy zzso zzso P zzso zzso and increasing percentage of zzso zzso zzso zzso for each zzso P zzso zzso Other significant zzso zzso zzso factors in these groups were bone zzso or brain zzso and previous zzso These data were used to create a model, assigning patients to groups at high, zzso or low risk for treatment interruption with zzso zzso patients may be candidates for clinical trials of a zzso growth zzso 

